Bristol Myers Squibb’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease. The company revealed Thursday that its PD-1 fighter, against placebo, had lengthened the time muscle-invasive urothelial carcinoma patients could remain disease-free after surgery. All patients saw benefit,… Read More »
The Centers for Medicare and Medicaid Services appears to be planning on cracking down on hospitals that do not report COVID-19 data daily into the U.S. Department of Health and Human Services’ HHS Protect TeleTracking system, reported NPR this week. A draft letter from the agency would require hospitals to report data, including the number… Read More »
With healthcare and the fate of Obamacare being significant election issues and Democrats scrambling for a way to stop Judge Amy Coney Barrett from joining the Supreme Court, Barrett’s position on the healthcare law, known as the Affordable Care Act, will likely be front-and-center at her confirmation hearing. Democratic members of Congress and presidential nominee… Read More »
“Lifestyle medicine is only for rich people, right?” a colleague asked me several years ago, questioning my involvement in this relatively new field of medicine that guides people toward healthy habits. This has been a common misperception, for sure. But across the US, a revitalized brand of health activism is intent on bringing lifestyle medicine… Read More »